339 related articles for article (PubMed ID: 6471209)
21. Routine bladder biopsy after bacille Calmette-Guérin treatment: is it necessary?
Skemp NM; Fernandes ET
Urology; 2002 Feb; 59(2):224-6. PubMed ID: 11834390
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma in situ of the bladder.
Utz DC; Farrow GM; Rife CC; Segura JW; Zincke H
Cancer; 1980 Apr; 45(7 Suppl):1842-8. PubMed ID: 7370935
[No Abstract] [Full Text] [Related]
23. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
Garbar C; Mascaux C; Wespes E
Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
[TBL] [Abstract][Full Text] [Related]
24. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
[TBL] [Abstract][Full Text] [Related]
25. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
26. Cytology and histopathology of bladder cancer cases in a prospective longitudinal study. National Bladder Cancer Collaborative Group A.
Cancer Res; 1977 Aug; 37(8 Pt 2):2911-5. PubMed ID: 872121
[No Abstract] [Full Text] [Related]
27. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
28. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
[TBL] [Abstract][Full Text] [Related]
29. Correlation of ABH antigenicity and urine cytology results in transitional cell carcinoma of bladder.
Gorelick JI; Oyasu R; Golmon ME; Grayhack JT
Urology; 1984 Sep; 24(3):287-90. PubMed ID: 6474644
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
31. Karyometry of bladder washings for the follow up of patients with transitional cell carcinoma of the bladder.
van der Poel HG; Oosterhof GO; Schaafsma HE; Wiersma-van Tilburg A; Debruyne FM; Schalken JA
Prog Clin Biol Res; 1992; 378():9-18. PubMed ID: 1301590
[No Abstract] [Full Text] [Related]
32. Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer?
Wiener HG; Remkes GW; Schatzl G; Susani M; Breitenecker G
Cancer; 1999 Oct; 87(5):263-9. PubMed ID: 10536351
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
[TBL] [Abstract][Full Text] [Related]
34. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
35. Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology.
Zhu YP; Shen YJ; Ye DW; Wang CF; Yao XD; Zhang SL; Dai B; Zhang HL; Shi GH
Urol Int; 2012; 88(1):84-7. PubMed ID: 22104957
[TBL] [Abstract][Full Text] [Related]
36. Value of random mucosal biopsies in the management of superficial bladder cancer.
Mufti GR; Singh M
Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505
[TBL] [Abstract][Full Text] [Related]
37. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
38. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
Cariou G; Maaraoui N; Cortesse A
Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
[TBL] [Abstract][Full Text] [Related]
39. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
[TBL] [Abstract][Full Text] [Related]
40. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
